Skip to content

The Beauty Health Company SKIN Convertible Debt (Non-Current)

Convertible Debt (Non-Current) at other companies

Richtech Robotics Inc. logo
Richtech Robotics Inc.RR
$118K+15.7%
Celcuity logo
CelcuityCELC
$195.57M
Wolfspeed logo
WolfspeedWOLF
$798.3M-73.8%
SKYX Platforms Corp. logo
SKYX Platforms Corp.SKYX
$14.52M+78.1%
Cineverse Corp. logo
Cineverse Corp.CNVS
$12.55M
RFL
Rafael Holdings, Inc.RFL
$2K-97.4%

Other financials

Income statement

See full
Revenue$64.9M-6.7%
Gross profit$44.4M-8.5%
Operating income-$1.8M+85.0%
Net income-$6.6M+34.3%
EPS (diluted)-$0.05+37.5%

Balance sheet

See full
Cash & equivalents$204.4M-45.2%
Total debt$125.9M+756%
Total equity$55.2M+19.9%
Total assets$473.2M-29.8%

Cash flow

See full
Operating cash flow-$5.6M-285%
CapEx$224.0K+398%
Free cash flow-$5.8M-296%

Valuation

See full
Market cap$89.75M-61.5%
Enterprise value$11.24M-96.2%
P/S0.3×-0.4×

Profitability

See full
Gross margin64.9%+8.3pp
Operating margin-3.6%-1.6pp
Net margin-2%-0.9pp
FCF margin9.6%

Returns & leverage

See full
Return on equity-12%-5.4pp
Debt / equity2.3×+2.0×
Current ratio1.8×-5.7×

Where this comes from

Reported directly by The Beauty Health Company in its filing.

Tagged under the XBRL concept us-gaap:ConvertibleDebtNoncurrent.

The official record: The Beauty Health Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about The Beauty Health Company's convertible debt (non-current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is The Beauty Health Company's convertible debt (non-current)?
The Beauty Health Company (SKIN) reported convertible debt (non-current) of $241.28M in Q1 2026.
How has The Beauty Health Company's convertible debt (non-current) changed year-over-year?
The Beauty Health Company's convertible debt (non-current) decreased by 56.4% year-over-year, from $552.98M to $241.28M.
What does convertible debt (non-current) mean?
This represents the portion of long-term debt obligations that can be converted into equity shares at the holder's option, with a maturity date exceeding one year. It serves as a critical indicator of potential future share dilution and long-term financial leverage. Investors monitor this balance to assess the company's capital structure flexibility and the potential impact of debt-to-equity conversions on existing shareholder value.